Poland· PL-100422979
Dexafree
A dexamethasone product containing dexamethasoni phosphas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamethasone is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BA01 (dexamethasone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Dexamethasone · ATC S01BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamethasone costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamethasone · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$362.24
The record
At a glance
URPL (Poland)- Active substance
- Dexamethasoni phosphas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01BA01
- ATC class
- Dexamethasone
- Defined daily dose
- 0.2 mg, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991409241
- gtin05909991409258
- gtin05909991409265
- gtin05909991409272
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
96 interactions on record for dexamethasone.
Graded by severity as the source publishes them — 41 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamethasone · interactions on record
96 records
- 41 moderate
- 55 minor
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01BA01
Dexamethasone, as other registers publish it.
- NetherlandsAxium-Opto 1mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
- FinlandAxiumoptoUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- DenmarkAxiumoptoUNI-Pharma Kleon
- BelgiumDarazon 1 mg/mlPharmaselect International Beteiligungs
- PolandDarazurPharmaselect International Beteiligungs GmbH
- CzechiaDARAZURPharmaselect International Beteiligungs GmbH, Vídeň
- CzechiaDARAZURPharmaselect International Beteiligungs GmbH, Vídeň
- PolandDemezonSun-Farm Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20ce6e41-29be-4e7e-a68f-4c7ab84ab39d GET /v1/drugs/20ce6e41-29be-4e7e-a68f-4c7ab84ab39d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909991409241 ¦ Rp ¦ 133376\n20 poj. 0,4 ml jednodawkowych\n05909991409258 ¦ Rp ¦ 133377\n30 poj. 0,4 ml jednodawkowych\n05909991409265 ¦ Rp ¦ 133378\n50 poj. 0,4 ml jednodawkowych\n05909991409272 ¦ Rp ¦ 133379\n100 poj. 0,4 ml jednodawkowych",
"substance": "Dexamethasoni phosphas 1 mg/ml",
"common_name": "Dexamethasoni phosphas",
"pl_product_id": "100422979",
"pozwolenie_nr": "250/19",
"auth_procedure": "IR",
"authorisation_validity": "2029-07-05"
}See everything about dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.